Aligos Therapeutics Inc (ALGS)
19.46
+0.01
(+0.05%)
USD |
NASDAQ |
Nov 14, 16:00
19.79
+0.33
(+1.70%)
After-Hours: 17:03
Aligos Therapeutics Price to Book Value: 1.394 for Nov. 14, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 1.393 |
| November 12, 2024 | 1.278 |
| November 11, 2024 | 1.002 |
| November 08, 2024 | 0.7298 |
| November 07, 2024 | 0.7105 |
| November 06, 2024 | 0.6697 |
| November 05, 2024 | 0.704 |
| November 04, 2024 | 0.679 |
| November 01, 2024 | 0.6338 |
| October 31, 2024 | 0.6491 |
| October 30, 2024 | 0.6484 |
| October 29, 2024 | 0.6212 |
| October 28, 2024 | 0.5887 |
| October 25, 2024 | 0.5575 |
| October 24, 2024 | 0.5993 |
| October 23, 2024 | 0.4785 |
| October 22, 2024 | 0.4871 |
| October 21, 2024 | 0.4838 |
| October 18, 2024 | 0.4812 |
| October 17, 2024 | 0.4785 |
| October 16, 2024 | 0.4898 |
| October 15, 2024 | 0.4825 |
| October 14, 2024 | 0.4798 |
| October 11, 2024 | 0.5057 |
| October 10, 2024 | 0.4573 |
| Date | Value |
|---|---|
| October 09, 2024 | 0.515 |
| October 08, 2024 | 0.4858 |
| October 07, 2024 | 0.4978 |
| October 04, 2024 | 0.5416 |
| October 03, 2024 | 0.5436 |
| October 02, 2024 | 0.5701 |
| October 01, 2024 | 0.5721 |
| September 30, 2024 | 0.5748 |
| September 27, 2024 | 0.3822 |
| September 26, 2024 | 0.3813 |
| September 25, 2024 | 0.3908 |
| September 24, 2024 | 0.3875 |
| September 23, 2024 | 0.3851 |
| September 20, 2024 | 0.4345 |
| September 19, 2024 | 0.484 |
| September 18, 2024 | 0.6732 |
| September 17, 2024 | 0.6841 |
| September 16, 2024 | 0.676 |
| September 13, 2024 | 0.7036 |
| September 12, 2024 | 0.667 |
| September 11, 2024 | 0.6561 |
| September 10, 2024 | 0.6556 |
| September 09, 2024 | 0.9237 |
| September 06, 2024 | 0.5947 |
| September 05, 2024 | 0.5676 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.2904
Minimum
May 06 2022
6.567
Maximum
Jun 11 2021
1.502
Average
0.6283
Median
May 05 2023
Price to Book Value Benchmarks
| Haemonetics Corp | 5.190 |
| Pliant Therapeutics Inc | 2.261 |
| CEL-SCI Corp | 4.065 |
| AIM ImmunoTech Inc | 2.719 |
| IGC Pharma Inc | 3.379 |
Price to Book Value Related Metrics
| PS Ratio | 17.68 |
| Price | 19.46 |
| Earnings Yield | -87.90% |
| Market Cap | 69.82M |